GC68778
BMS-262084
Also known as (2S,3R)-1-[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]-3-[3-(diaminomethylideneamino)propyl]-4-oxoazetidine-2-carboxylic acid
BMS-262084 is an effective, selective, and irreversible inhibitor of factor XIa with an IC50 value of 2·8 nM for human factor XIa· BMS-262084 also inhibits human pancreatic trypsin (IC50=5 nM)· BMS-262084 has anti-thrombotic properties
ChemicalCAS253174-92-4MW425.48FormulaC18H31N7O5
- CAS number
- 253174-92-4
- Molecular weight
- 425.48
- Formula
- C18H31N7O5
- Solubility
- DMSO ： 50 mg/mL (117·51 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- MFTQITSPGQORDA-NEPJUHHUSA-N
- Catalogue number
- GC68778
- Brand
- GLPBIO
Computed properties PubChem CID 9802488 · XLogP -1.9 · TPSA 175 Ų · H-bond donors 4
- XLogP
- -1.9
- TPSA
- 175 Ų
- H-bond donors
- 4
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 30
SMILES CC(C)(C)NC(=O)N1CCN(CC1)C(=O)N2[C@@H]([C@H](C2=O)CCCN=C(N)N)C(=O)O
Computed descriptors from PubChem (CID 9802488), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il